KALA BIO Statistics
KALA BIO (27F) Stock Statistics & Valuation Metrics
Total Valuation
KALA BIO has a market cap or net worth of EUR 2.69M. The enterprise value is -EUR 7.10M.
- Market Cap
- EUR 2.69M
- Enterprise Value
- -EUR 7.10M
Share Statistics
KALA BIO has 19,339,787 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 19,339,787
- Owned by Insiders
- ―
- Owned by Institutions
- 3.10%
Financial Efficiency
KALA BIO’s return on equity (ROE) is -3.86 and return on invested capital (ROIC) is -559.76%.
- Return on Equity (ROE)
- -3.86
- Return on Assets (ROA)
- -2.84
- Return on Invested Capital (ROIC)
- -559.76%
- Return on Capital Employed (ROCE)
- -5.60
- Revenue Per Employee
- 0
- Profits Per Employee
- -4.50M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of KALA BIO is -0.00. KALA BIO’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.17
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, KALA BIO had revenue of 0 and earned -26.98M in profits. Earnings per share was -165.50.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -39.16M
- Pretax Income
- -26.98M
- Net Income
- -26.98M
- EBITDA
- -23.39M
- Earnings Per Share (EPS)
- -165.50
Cash Flow
In the last 12 months, operating cash flow was -19.86M and capital expenditures 0, giving a free cash flow of -19.86M billion.
- Operating Cash Flow
- -19.86M
- Free Cash Flow
- -19.86M
- Free Cash Flow per Share
- -267.84
Dividends & Yields
KALA BIO pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -590.26%
- Earnings Yield
- -78117.34%
Stock Price Statistics
- Beta
- 1.49
- 52-Week Price Change
- -88.92%
- 50-Day Moving Average
- 3.40
- 200-Day Moving Average
- 6.04
- Relative Strength Index (RSI)
- 23.46
- Average Volume (3m)
- ―
Important Dates
KALA BIO upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
KALA BIO as a current ratio of 3.81, with Debt / Equity ratio of 0.00%
- Current Ratio
- 3.81
- Quick Ratio
- 3.81
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.32
- Interest Coverage Ratio
- -11.95
Taxes
In the past 12 months, KALA BIO has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
KALA BIO EV to EBITDA ratio is -0.36, with an EV/FCF ratio of -0.16.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.36
- EV to Free Cash Flow
- -0.16
- EV to Operating Cash Flow
- -0.16
Balance Sheet
KALA BIO has EUR 7.23M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 7.23M billion.
- Cash & Marketable Securities
- EUR 7.23M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 7.23M
- Net Cash Per Share
- EUR 0.37
- Tangible Book Value Per Share
- EUR 121.95
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for KALA BIO is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 79.71%
